Editorial Advisory Group (Clinical Oncology Journal)

Professor Thankamma Vadakkeveedu Ajithkumar, MD, FRCR, FRCPEdin, MBA

Cambridge, United Kingdom

Professor Ann Henry, FRCR, MD

Leeds, United Kingdom

J. P. Agarwal, DMRT, MD

Mumbai, India

Head and neck cancer, lung cancer

S. Ahmad

Cambridge, United Kingdom

S. Chatterjee, FRCP, FRCR, PGCE, FHEA

Kolkata, India

Breast cancer, head and neck cancer, post graduate medical education

G. Delaney, AM, FRANZCR, PhD, MD, MBBS

Liverpool, Australia

Breast cancer, big data, health services research, equity

S. Gaito

London, United Kingdom

Paediatric, teenagers and young adults, cranial and extracranial malignancies, adult CNS

D. C. Gilbert, MRCP, FRCR, PhD

Brighton, United Kingdom

Pelvic malignancies, translational research, late-stage clinical trials, optimisation approaches

G. G. Hanna

Belfast, United Kingdom

S. Harrow, MRCP, FRCR, MBChB, PhD

Edinburgh, United Kingdom

Lung cancer, thymic cancer, mesothelioma, oligometastatic disease, AI and innovation

S. Iqbal, MBBS (Pak), MRCP (Ireland), FRCR (UK), PG Cert Medical Research (Newcastle University)

Newcastle, United Kingdom

Head and neck cancer, thyroid cancer

S. Jain, MB, BCh, PhD

Belfast, United Kingdom

Prostate cancer

K. Joseph, MBBS, FFRRCSI, FRCR, FRCPC

Edmonton, Canada

GI, cutaneous malignancies

N. Joseph, MBBS, MD, MRCP, FRCR

Colombo, Sri Lanka

Urology, radiobiology, clinical oncology, global oncology, immunooncology, head and neck cancer

E-S. Koh, MBBS, FRANZCR

Sydney, Australia

Neuro-oncology, haematology, cancer survivorship and late effects, clinical trials

T. Kron, FACPSEM, FCCPM

Melbourne, Australia

Medical physics

V. Lee, MBBS, MD, FRCR, FHKCR, FHKAM (Radiology)

Hong Kong, Hong Kong

Nasopharyngeal carcinoma, head and neck cancer, lung cancer, HPB and pancreatic malignancies, novel radiation therapy techniques

A. McWilliam, PhD

Manchester, United Kingdom

Medical physics

D. J. Noble, MSc (Dist), PhD, MRCP, FRCR

Edinburgh, United Kingdom

Head and neck cancer, image analysis, radiomics, adaptive radiotherapy, biomarkers, predictive modelling, data science, machine learning, AI

S. O'Cathail

Glasgow, United Kingdom

Lower GI

B. O'Leary, MA Cantab, MBBS, MSc, MRCP, FRCR, PhD

London, United Kingdom

Head and neck cancer, translational research

G. Price

Manchester, United Kingdom

Medical physics

A. I. Rembielak, MD, PhD, BSc, MA, FRCR

Manchester, United Kingdom

Non-melanoma skin cancer, palliative radiotherapy, brachytherapy, geriatric oncology, medical education, quality of life

B. Sanghera, PhD, MSc, BSc

London, United Kingdom

PET scanning, image analysis

Y. Song, MB, BCh, MRCP, FRCR, MD

Manchester, United Kingdom

Bladder cancer, prostate cancer, brachytherapy

A. Stewart, MD, MRCP, FRCR

Guilford, United Kingdom

Brachytherapy, gynae-oncology, anal cancer, rectal cancer, quality of life, survivorship

I. Syndikus, MD, MRCP, FRCR

Liverpool, United Kingdom

Prostate cancer, bladder cancer, radiotherapy

C. Talbot

Leicester, United Kingdom

Radiogenomics, radiobiology, prediction modelling

K. Thippu, MBBS, MSc, MD, MRCP (UK), FRCR

Cambridge, United Kingdom

SABR, prostate cancer, lung cancer, bladder cancer, clinical trials, advanced radiotherapy techniques, AI in radiotherapy, radiobiology

Y. M. Tsang, PhD, FCR by Portfolio

Toronto, Canada

Radiotherapy trial quality assurance, ultra-hypofractionated/stereotactic radiotherapy treatment outcomes, strategies to future-proof therapeutic radiographer/radiation therapist practice

L. Wang, MBBS, FRCR

London, United Kingdom

A. Wilkins, PhD, MB/BChir, FRCR

London, United Kingdom

Bladder cancer, prostate cancer, tumour microenvironment, cancer-associated fibroblasts

K-W. Yeoh

Singapore, Singapore

Global health oncology, hematological malignancies, combined-modality treatment in clinical oncology

C. Crockett, MB, BCh, BAO, MRCP, FRCR

Belfast, United Kingdom

Lung cancer, head and neck cancer, skin cancer

C. Lorimer, MBBS, MD

Brighton, United Kingdom

Neuro oncology, geriatric oncology, uro-oncology, thyroid cancer

G. Jones, MD

Boston, United States of America

Radiation Oncology

K. Makori, MD

Kisii, Kenya

Radiation oncology, global oncology, clinical trials, immunotherapy

R. Simões

London, United Kingdom

Radiotherapy, image-guided radiotherapy, soft tissue sarcoma of extremities, radiotherapy planning

F. M. Slevin, FRCR, PhD

Leeds, United Kingdom

Uro-oncology, stereotactic ablative radiotherapy, re-irradiation

G. Radhakrishna, MbCHB, MRCP, FRCR, Masters Clin Ed, MAcadMEd

Manchester, United Kingdom

Terms of Reference for the Journal Editorial Advisory Groups

· "Each journal will have its own Editorial Advisory Group with a membership determined by the Editor, but made up of doctors, researchers and academics who can support and enable the Journal's editorial ambitions."

· "Members of the group do not have to be RCR Fellows if they contribute a particular strength, for example their academic contacts or profile. Lay members are not required in the Editorial Advisory Group."

· "The Editorial Advisory Group does not have decision-making power other than around editorial initiatives, for example commissioning and editing."

· "The Editorial Advisory Groups can meet as often as the Editor sees fit, with a minimum of two meetings a year. The RCR is responsible for organising up to two of these meetings a year."

Each Journal Editorial Advisory Group serves to:

· Discuss and advise on key editorial initiatives.

· Discuss and advise on attracting papers to the journal.

· Discuss and advise on editorial challenges.

· Discuss any ideas or initiatives that might be put forward to the Journals Board.

· Support the editor in the day-to-day work associated with the Journal.

Approved by the Trustee Board: 26 April 2024